Akinci Seda B, Saricaoğlu Fatma, Atay Ozgur Ahmet, Doral Mahmut Nedim, Kanbak Meral
Department of Anesthesiology and Reanimation, Hacettepe University, Sihhiye Ankara, Turkey.
Arthroscopy. 2005 Sep;21(9):1060-5. doi: 10.1016/j.arthro.2005.05.012.
PURPOSE: The aim of the study was to compare the analgesic effect of 5 mg intra-articular (IA) morphine with 50 mg IA tramadol. TYPE OF STUDY: Prospective double-blind randomized trial. METHODS: Seventy-five patients having elective arthroscopic surgery of the knee were randomized to receive IA tramadol 50 mg (tramadol group), IA morphine 5 mg (morphine group), or IA normal saline (control group), in equivalent volumes (20 mL). The tourniquet was released 10 minutes after analgesic administration. Verbal pain rating score between 0 and 10 (VRS), supplemental analgesic requirements, and incidence of side effects were recorded postoperatively. RESULTS: Results are given as (median [5-95 percentiles]). The control group had a significantly shorter time to first analgesic request (25 min [15-55]) than morphine group, (34 min [15-158], P < .008) and the tramadol group, (33 min [17-728], P < .008). The patients in the control group complained of more severe pain (VRS 7 [4-10]) when they arrived at the postanesthesia care unit compared with the morphine group (VRS 1 [0-9], P = .002) and with the tramadol group (VRS 0 [0-9], P = .002). These treatment benefits were especially prominent in the patients who had meniscectomy or in the subgroup of patients with more than 6 months of preoperative pain. There was no statistical difference between the tramadol and morphine groups in the time to first analgesia, postoperative pain scores after arrival at the postanesthesia care unit, consumption of rescue analgesic, or side effects. CONCLUSIONS: We conclude that 50 mg IA tramadol provides analgesia equivalent to 5 mg IA morphine. LEVEL OF EVIDENCE: Level II, randomized controlled trial that shows no significant difference and lacks narrow confidence intervals.
目的:本研究旨在比较5毫克关节内注射吗啡与50毫克关节内注射曲马多的镇痛效果。 研究类型:前瞻性双盲随机试验。 方法:75例行择期膝关节镜手术的患者被随机分为三组,分别接受20毫升等量的关节内注射50毫克曲马多(曲马多组)、关节内注射5毫克吗啡(吗啡组)或关节内注射生理盐水(对照组)。镇痛药物给药10分钟后松开止血带。术后记录0至10分的言语疼痛评分(VRS)、补充镇痛药物的需求以及副作用发生率。 结果:结果以(中位数[第5 - 95百分位数])表示。对照组首次镇痛需求的时间(25分钟[15 - 55])明显短于吗啡组([34分钟[15 - 158],P < 0.008])和曲马多组([33分钟[17 - 728],P < 0.008])。与吗啡组(VRS 1[0 - 9],P = 0.002)和曲马多组(VRS 0[0 - 9],P = 0.002)相比,对照组患者到达麻醉后护理单元时主诉疼痛更剧烈(VRS 7[4 - 10])。这些治疗益处在接受半月板切除术的患者或术前疼痛超过6个月的患者亚组中尤为显著。曲马多组和吗啡组在首次镇痛时间、到达麻醉后护理单元后的术后疼痛评分、急救镇痛药的消耗量或副作用方面无统计学差异。 结论:我们得出结论,50毫克关节内注射曲马多提供的镇痛效果与5毫克关节内注射吗啡相当。 证据水平:二级,随机对照试验,显示无显著差异且缺乏狭窄的置信区间。
CNS Drugs. 2019-5
Cochrane Database Syst Rev. 2016-5-3